BioSpace News Archive

The Novartis Oncology Young Canadian Investigator Awards (NOYCIA) returns for its 21st year at ASCO 2024

Novartis Canada is pleased to announce the winners of the 2024 Novartis Oncology Young Canadian Investigator Awards, an annual national competition dedicated to advancing oncology through the promotion of research by supporting Canadian oncology researchers.

June 11, 2024
·
4 min read
Kardium Announces $104M in New Financing for Innovative Atrial Fibrillation Treatment

Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $104 million in a new financing round.

June 11, 2024
·
2 min read
Biotech Beach

Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations

Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the launch of DRAGEN™ v4.3, the latest version of its DRAGEN™ software, part of the Illumina Connected Software portfolio, for analysis of next-generation sequencing data.

June 11, 2024
·
5 min read
Genetown

BostonGene and Collaborators Honored with GRASP Advocate Choice Award at the 2024 ASCO Annual Meeting

BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced the presentation of its poster at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting has received the GRASP Advocate Choice Award.

June 11, 2024
·
2 min read
BioMidwest

Nimble Announces Formation of a World-Class Scientific Advisory Board

Nimble Therapeutics announced the formation of the Nimble Scientific Advisory Board to support the company’s mission to create orally delivered peptide therapeutics to treat immune-mediated diseases.

June 11, 2024
·
5 min read
Business

The Feinstein Institutes 2024 Ross Prize awarded to Stanford University’s Dr. Michelle Monje

The Feinstein Institutes for Medical Research has selected Michelle Monje, MD, PhD, from Stanford University, to receive the 11th annual Ross Prize in Molecular Medicine for her outstanding contributions to research relating to the neuroscience of cancer and its implications for therapy.

June 11, 2024
·
7 min read
Pharm Country

Origin Life Sciences Abstract Accepted for Presentation at 2024 Military Health System Research Symposium (MHSRS) Discussing Innovative Technologies and Devices for Treatment of Battlefield Wounds in Prolonged Care to Prevent Infection

Origin Life Sciences, Inc. announced that the Company’s abstract, titled: “NO: a Novel, Pathogen-Agnostic Therapy for Treatment-Resistant Wound Infections in the Warfighter,” has been accepted for presentation at 2024 Military Health System Research Symposium.

June 11, 2024
·
6 min read
Press Releases

U.S. Antisense And RNAi Therapeutics Market Size to Hit USD 17.87 Bn by 2033

June 11, 2024
·
12 min read
BioMidwest

New Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets

SPR® Therapeutics, a leader in the use of peripheral nerve stimulation (PNS) to address different types of pain throughout the body, announced the publication of a review of prospective studies evaluating the impact on chronic pain following percutaneous PNS treatment.

June 11, 2024
·
4 min read
Next-gen Biomanufacturing Market Size to Reach US$39.4 Billion by 2032

As per the Vantage Market Research Latest Report, the Global Next-gen Biomanufacturing Market is predicted to grow at a CAGR of 7.5% between 2024 and 2032

June 11, 2024
·
8 min read